New Daily Pill Shows Promise for Diabetes and Weight
A new phase 3 trial reveals that a daily oral pill called orforglipron could provide a highly effective, injection-free alternative for managing type 2 diabetes and body weight.
Read AnalysisNew Drug Combo Accelerates Fat Loss While Protecting Muscle
A new clinical trial shows that pairing the antibody bimagrumab with semaglutide leads to dramatic fat loss while helping preserve critical muscle mass.
Read AnalysisWomen Lose More Weight Than Men on GLP-1 Medications
A new analysis reveals that popular GLP-1 medications lead to significantly more percentage body mass reduction in women than in men.
Read AnalysisPopular GLP-1 Drug Fails to Slow Alzheimer's Disease Progression
Despite early promise, a large clinical trial reveals that the popular GLP-1 drug semaglutide does not slow down cognitive decline in early-stage Alzheimer's disease.
Read AnalysisSemaglutide May Outperform Tirzepatide for Heart Health in Obesity
A new real-world study suggests semaglutide provides greater protection against major cardiovascular events than tirzepatide in overweight adults with prior heart disease.
Read AnalysisTirzepatide Lowers Heart Attack and Stroke Risks in Diabetes
A new analysis of real-world data reveals that the popular medication tirzepatide significantly lowers the risk of heart attacks, stroke, and early death in people with type 2 diabetes.
Read AnalysisPopular Diabetes Drugs May Protect Against Worsening Mental Health
New research suggests that medications like semaglutide could actually protect against worsening anxiety and depression rather than exacerbating them.
Read AnalysisSemaglutide Protects Against Osteoarthritis Even Without Weight Loss
Semaglutide could relieve osteoarthritis pain and repair cartilage by changing how joint cells use energy, rather than just by shedding pounds.
Read AnalysisNew Guidelines: How Semaglutide Treats Fatty Liver Disease
Liver experts have released new guidelines on using the popular drug semaglutide to treat a serious form of fatty liver disease.
Read Analysis